§ 170.315(b)(8)
Security tags – summary of care – receive
Get Email Updates
Certification Companion Guide
Test Procedure
Certification Companion Guide
v1.3
View Changelog
Issued Date:
03-11-2024
08-29-2025
This Certification Companion Guide (CCG) is an informative document designed to assist with health IT product certification. The CCG is not a substitute for the requirements outlined in regulation and related ONC final rules. It extracts key portions of ONC final rules’ preambles and includes subsequent clarifying interpretations. To access the full context of regulatory intent please consult the
Certification Regulations
page for links to all ONC final rules or consult other regulatory references as noted. The CCG is for public use and should not be sold or redistributed.
Archived Version:
§ 170.315(b)(8) Data segmentation for privacy - receive CCG
Quick Overview
Required Updates
None
Design and Performance
Additional Criterion Information
Base EHR Definition
Not Included
Real World Testing
Yes
Insights Condition
No
SVAP Versions
Yes
CLARIFICATIONS
REGULATORY
STANDARDS
DEPENDENCIES
RESOURCES
CHANGELOG
IN THIS SECTION
Certification Clarifications
Technical Explanations and Clarifications
Search and Filter
Search Here...
Filter By Paragraph
All
Paragraph (b)(8)(i)
Paragraph (b)(8)(ii)
Sort:
Clarifications:
Through the
C-CDA Patch Process
, the HL7® Structured Documents Work Group (SDWG) approves C-CDA “patches”, which are corrections for issues with the C-CDA implementation guide (C-CDA IG) and companion guides. C-CDA “patches” include corrections for issues such as ambiguous requirements and requirements incompatible with real world deployment. Similar to C-CDA “patches” are C-CDA “additional guidance”. C-CDA “additional guidance” approved by the SDWG indicates guidance included in a newer version of the C-CDA IG or companion guide as being relevant to a previous version of the C-CDA IG or companion guide. A C-CDA “patch” may require a code change to correct errors or ambiguities in the guide, while “additional guidance” is purely clarifying and does not require any code changes. Though C-CDA “patches” and “additional guidance” are not required for certification purposes (unless indicated in the Certification Companion Guide), health IT developers may optionally implement C-CDA “additional guidance” in their Health IT Module and still be conformant with § 170.315(b)(7) criterion requirements.
More information regarding the C-CDA Patch Process and C-CDA “patches” and “additional guidance” approved by the SDWG is available on the HL7® Confluence pages of
C-CDA 'Patch' Process
and
Approved Patches and Additional Guidance
STANDARDS REFERENCED
§ 170.205(a)(4)
Health Level 7 (HL7®) Implementation Guide for CDA Release 2 Consolidation CDA Templates for Clinical Notes (US Realm), Draft Standard for Trial Use Release 2.1 C-CDA 2.1, August 2015, June 2019 (with Errata)
§ 170.205(o)(1)
HL7® Implementation Guide: Data Segmentation for Privacy (DS4P), Release 1
Technical outcome - The health IT must be able to receive a summary record (formatted to Consolidated CDA (C-CDA) Release 2.1) that is document, section, and entry level tagged as restricted and subject to re-disclosure restrictions using the HL7® Implementation Guide: Data Segmentation for Privacy (DS4P), Release 1.
Clarifications:
The DS4P standard does not have a service discovery mechanism to determine if a potential recipient is able to receive a tagged document. ONC expects that providers will have to determine the receiving capabilities of their exchange partners. This is similar to how providers have to work with their exchange partners today when manually exchanging sensitive health information via fax. [see
80 FR 62648
In order to mitigate potential interoperability errors and inconsistent implementation of the HL7® Implementation Guide for CDA® Release 2: Consolidated CDA Templates for Clinical Notes, Draft Standard for Trial Use, Release 2.1, ONC assesses, approves, and incorporates corrections as part of required testing and certification to this criterion. [see the
Health IT Certification Program Overview
] Certified health IT adoption and compliance with the following corrections are necessary because they implement updates to vocabularies, update rules for cardinality and conformance statements, and promote proper exchange of C-CDA documents. There is a 90-day delay from the time the CCG has been updated with the ONC-approved corrections to when compliance with the corrections will be required to pass testing (i.e., Edge Testing Tool: Message Validators). Similarly, there will be an 18-month delay before a finding of a correction’s absence in certified health IT during surveillance would constitute a non-conformity under the Certification Program.
Technical outcome – The privacy markings must be preserved to ensure fidelity to the tagging based on consent and with respect to sharing and re-disclosure restrictions.
Clarifications:
No additional clarifications.
Regulation Text
§ 170.315 (b)(8) Security tags – summary of care – receive.
(i) Enable a user to receive a summary record that is formatted in accordance with the standard adopted in § 170.205(a)(4) that is tagged as restricted and subject to restrictions on re-disclosure according to the standard adopted in § 170.205(o)(1) at the document, section, and entry (data element) level; and
(ii) Preserve privacy markings to ensure fidelity to the tagging based on consent and with respect to sharing and re-disclosure restrictions.
Standards & References
The following standards are referenced within the certification criteria for:
§ 170.315(b)(8) Security tags - summary of care - receive
View By
Standard
Paragraph
§ 170.205(a)(4)
Health Level 7 (HL7®) Implementation Guide for CDA Release 2 Consolidation CDA Templates for Clinical Notes (US Realm), Draft Standard for Trial Use Release 2.1 C-CDA 2.1, August 2015, June 2019 (with Errata)
Referenced in the Following:
§170.315(b)(8)
SVAP-approved Versions:
HL7 CDA® R2 Implementation Guide: Consolidated -CDA Templates for Clinical Notes Edition 4.0 - US Realm
§ 170.205(o)(1)
HL7® Implementation Guide: Data Segmentation for Privacy (DS4P), Release 1
Referenced in the Following:
§170.315(b)(8)
§170.315(b)(8)
Applies to Entire Criterion
§ 170.205(a)(4)
Health Level 7 (HL7®) Implementation Guide for CDA Release 2 Consolidation CDA Templates for Clinical Notes (US Realm), Draft Standard for Trial Use Release 2.1 C-CDA 2.1, August 2015, June 2019 (with Errata)
§ 170.205(o)(1)
HL7® Implementation Guide: Data Segmentation for Privacy (DS4P), Release 1
Certification Dependencies
§ 170.405
Real World Testing
Products certified to this criterion must complete requirements outlined for the Real World Testing Conditions and Maintenance of Certification.
Note: For calendar year (CY) 2025, a developer is not expected to submit an annual Real World Testing plan to its ONC-Authorized Certification Body (ONC-ACB) for the 2026 Real World Testing year. For CY 2026, ONC only expects a developer with a Health IT Module(s) certified to the (g)(7) through (10) certification criteria, as of August 31, 2024, to submit a CY 2025 Real World Testing results report to its ONC-ACB by March 2026.
Please read the full notice
outlining the details of the Real World Testing enforcement discretion.
Privacy and Security
This certification criterion was adopted at § 170.315(b)(8). As a result, an ONC Authorized Certification Body (ONC-ACB) must ensure that a product presented for certification to a § 170.315(b) criterion includes the privacy and security criteria (adopted in § 170.315(d)) within the overall scope of the certificate issued to the product.
The privacy and security criteria (adopted in § 170.315(d)) do not need to be explicitly tested with this specific paragraph (b) criterion unless it is the only criterion for which certification is requested.
As a general rule, a product presented for certification only needs to be tested once to each applicable privacy and security criterion (adopted in § 170.315(d)) so long as the health IT developer attests that such privacy and security capabilities apply to the full scope of capabilities included in the requested certification. However, exceptions exist for § 170.315(e)(1) “View, download, and transmit to 3rd party (VDT)” and (e)(2) “Secure messaging,” which are explicitly stated.
For more information on the approaches to meet these Privacy and Security requirements, please download the Privacy and Security CCG below:
Privacy and Security CCG
If choosing
Approach 1
Authentication, access control, and authorization (§ 170.315(d)(1))
Auditable events and tamper-resistance (§ 170.315(d)(2))
Audit reports (§ 170.315(d)(3))
Automatic access time-out (§ 170.315(d)(5))
Emergency access (§ 170.315(d)(6))
End-user device encryption (§ 170.315(d)(7))
Integrity (§ 170.315(d)(8))
Encrypt user credentials (§ 170.315(d)(12))
Multi-factor authentication (§ 170.315(d)(13))
If choosing
Approach 2
For each applicable privacy and security certification criterion not certified for Approach 1, the health IT developer may certify for the criterion using system documentation which is sufficiently detailed to enable integration such that the Health IT Module has implemented service interfaces that enable the Health IT Module to access external services necessary to meet the requirements of the privacy and security certification criterion. Please see the ONC Cures Act Final Rule at
85 FR 25710
for additional clarification.
Design and Performance
The following design and performance certification criteria (adopted in § 170.315(g)) must also be certified in order for the product to be certified.
Quality management system (§ 170.315(g)(4))
: When a single quality management system (QMS) is used, the QMS only needs to be identified once. Otherwise, when different QMS are used, each QMS needs to be separately identified for every capability to which it was applied.
Accessibility-centered design (§ 170.315(g)(5))
: When a single accessibility-centered design standard is used, the standard only needs to be identified once. Otherwise, the accessibility-centered design standards need to be identified for every capability to which they were applied; or, alternatively, the developer must state that no accessibility-centered design was used.
Resources
The following resources can offer assistance or additional information:
§ 170.315(b)(8) Security tags - summary of care - receive
PDF DOCUMENT
Real World Testing Resource Guide
2025-10-01
PDF DOCUMENT
Real World Testing Fact Sheet
Certification Companion Guide Changelog
The following changelog applies to:
§ 170.315(b)(8)Security tags – summary of care – receive
Changelog functionality is not available.
Revision History
Version #
Description of Change
Version Date
1.0
Initial Publication
03-11-2024
1.1
Standards Referenced updated to reflect 2024 Approved SVAP Standards
08-19-2024
1.2
Added clarification for entire criterion providing information regarding C-CDA patch process. Added update to Certification Dependencies section to reflect recent Real World Testing enforcement discretion notice.
07-23-2025
1.3
Standards Referenced updated to reflect 2025 Approved SVAP Standards
08-29-2025
Test Procedure
v1.2
View Changelog
Issued Date:
03-11-2024
03-21-2025
This Test Procedure illustrates the test steps required to certify a Health IT Module to this criterion. Please consult the most recent ONC Final Rule on the
Certification Regulations
page for a detailed description of the certification criterion with which these testing steps are associated. ASTP/ONC also encourages developers to consult the Certification Companion Guide in tandem with the test procedure as it provides clarifications that may be useful for product development and testing.
Archived Version:
§ 170.315(b)(8) Data segmentation for privacy - receive TP
Quick Overview
Required Updates
None
Design and Performance
Additional Criterion Information
Base EHR Definition
Not Included
Real World Testing
Yes
Insights Condition
No
SVAP Versions
Yes
TESTING STEPS
TOOLS AND DATA
TESTING COMPONENTS
CHANGELOG
IN THIS SECTION
View Regulation Text
Testing Steps
Note: The tests step order does not necessarily prescribe the order in which the tests should take place.
Search and Filter
Search Here...
Filter By Paragraph
Filter By Date
Sort:
Testing Steps
System Under Test
System Under Test Instruction
Summary records in accordance with the test steps below, based on the health IT setting(s), are provided by the ASTP Standards Implementation & Testing Environment (SITE): C-CDA Validator under the “Receiver” system.
The health IT developer identifies the policies associated with the handling of the DS4P documents.
Receive
Using the Health IT Module, a user receives summary record document(s) formatted in accordance with the standard specified at § 170.205(a)(4) HL7
Implementation Guide for CDA
Release 2: Consolidated CDA Templates for Clinical Notes, DSTU Release 2.1, that is tagged as restricted and subject to restrictions on re-disclosure, according to the standard adopted at § 170.205(o)(1) HL7
Implementation Guide: Data Segmentation for Privacy (DS4P), Release 1, which includes the following:
Privacy Segmented Document Template;
Clinical Document Architecture (CDA) Mandatory Document Provenance;
CDA Mandatory Document Assigned Author Template;
If a document contains information protected by specific privacy policies, the CDA Privacy Markings Section and Privacy Marking Entry(ies);
Privacy Segmented Section Template(s); Privacy Annotation Template; and
Protected Problem Template.
The received Consolidated- Clinical Document Architecture (C- CDA) tagged as restricted document received in step 3, includes the following data elements:
The originating document Individual Author or Organization; and
Confidentiality Code constrained in accordance with the standard specified in § 170.205(o)(1) HL7
Implementation Guide: Data Segmentation for Privacy (DS4P), Release 1.
Using the Health IT Module, a user receives a summary record document(s) formatted in accordance with the standard specified at § 170.205(a)(4) HL7
Implementation Guide for CDA
Release 2: Consolidated CDA Templates for Clinical Notes, DSTU Release 2.1, without any restrictions.
All Steps
Approved SVAP Version)
Complete steps above using SITE: C-CDA Validator for USCDI v4 and;
Use HL7® CDA® R2 Implementation Guide: Consolidated CDA Templates for Clinical Notes Edition 3.0 - US Realm, May 2024 for § 170.205(a)(4), (a)(5) or (a)(6).
Test Lab Verification
Test Lab Instruction
The tester creates a human-readable version for each of the documents received in steps 3-5, of the System Under Test to be used for verification.
The tester verifies the health IT developer has provided identification of the policies associated with the handling of the DS4P documents.
Receive
The tester verifies a Health IT Module can receive a summary record document formatted in accordance with the standard specified at § 170.205(a)(4) that is document-level section-level and entry-level tagged as restricted and contains restrictions on re-disclosure according to the standard adopted at § 170.205(o)(1) for each health IT setting being certified, using visual inspection of the following:
Privacy Segmented Document Template;
CDA Mandatory Document Provenance;
CDA Mandatory Document Assigned Author Template;
If a document contains information protected by specific privacy policies, the CDA Privacy Markings Section and Privacy Marking Entry(ies);
Privacy Segmented Section Template(s);Privacy Annotation Template; and
Protected Problem Template.
The tester verifies the document received includes the following data elements:
The originating document Individual Author or Organization; and
Confidentiality Code constrained in accordance with the standard specified in § 170.205(o)(1) HL7
Implementation Guide: Data Segmentation for Privacy (DS4P), Release 1.
The tester verifies a Health IT Module can receive a summary record document formatted in accordance with the standard specified at § 170.205(a)(4) that is not document-level tagged as restricted for each health IT setting being certified, using visual inspection.
Testing Steps
System Under Test
The health IT developer attests that privacy markings are preserved by the Health IT Module to ensure fidelity to the tagging based on consent and with respect to sharing and re-disclosure restrictions.
Test Lab Verification
The tester verifies the health IT developer attests that the Health IT Module preserves privacy markings to ensure fidelity to the tagged based on consent and with respect to sharing and re-disclosure restrictions.
TEST TOOL DOCUMENTATION
Testing Tools
§ 170.315(b)(8) Security tags - summary of care - receive
Standards Implementation & Testing Environment (SITE)
C-CDA Validators
SITE is a centralized collection of testing tools and resources designed to assist health IT developers and health IT users fully evaluating specific technical standards and maximizing the potential of their health IT implementations. SITE is organized in a collection of sandboxes that provide test tools, sample data, collaboration resources, and useful links.
Test Data
Test data for implementation and validation.
(b)(8)(i)
Inpatient setting: 170.315_b8_ds4p_inp_sample1*.xml
Ambulatory setting: 170.315_b8_ds4p_amb_sample1*.xml
Testing Components
§ 170.315(b)(8) Security tags - summary of care - receive
Documentation is an approved method to demonstrate conformance. This may include documents from the health IT developer or third-party that demonstrate/attest to the compliance with the criterion.
Visual inspection is an approved method to demonstrate conformance. Most commonly, this will be accomplished via a live demonstration of functionality that meets the criterion.
Testing Tools
Testing tools indicate that a test tool(s) exists and must be used to test a portion or all of a Health IT Module's conformance to the criterion.
SVAP
Indicates that the Standards Version Advancement Process (SVAP) is applicable to the criterion.
Test Data
The test data for this criterion is provided within the testing tools tab. Click the link below to be directed to the testing tools tab.
Review Test Data
Test Method Changelog
The following changelog applies to:
§ 170.315(b)(8)Security tags – summary of care – receive
Changelog functionality is not available.
Revision History
Version #
Description of Change
Version Date
1.0
Initial Test Procedure
03-11-2024
1.1
Updated test tool link
12-02-2024
1.2
Updated test steps with 2024 SVAP approved standards and new SITE UI language. Updated regulatory language to reflect changes in HTI-2 Final Rule.
03-21-2025
The following design and performance certification criteria (adopted in § 170.315(g)) must also be certified for the product to be certified.
Additional Criteria:
§ 170.315(g)(4)
Quality management system
Description:
When a single quality management system (QMS) is used, the QMS only needs to be identified once. Otherwise, when different QMS are used, each QMS needs to be separately identified for every capability to which it was applied.
§ 170.315(g)(5)
Accessibility-centered design
Description:
When a single accessibility-centered design standard is used, the standard only needs to be identified once. Otherwise, the accessibility-centered design standards need to be identified for every capability to which they were applied; or, alternatively, the developer must state that no accessibility-centered design was used.
Loading Privacy & Security content...
Standards Version Advancement Process (SVAP)
The Standards Version Advancement Process (SVAP) permits health IT developers to voluntarily update health IT products certified under the ONC Health IT Certification Program (Certification Program) to newer versions of adopted standards as part of the "Real World Testing" Condition and Maintenance of Certification requirement (§ 170.405) of the 21st Century Cures Act.
Learn More About SVAP
SVAP Approved Version:
HL7 CDA® R2 Implementation Guide: Consolidated -CDA Templates for Clinical Notes Edition 4.0 - US Realm
Related to standard reference: § 170.205(a)(4)
External Link Notice
Welcome to HealthIT.gov!
Thank you for visiting the HealthIT.gov website! We welcome your feedback using the "Submit Feedback" button at the bottom of the page to help us improve your experience!